Drug Trial Radar · NCT03028350
Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
Last checked: Nov 19, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Jul 17, 2017
Primary completion
Apr 25, 2023
Study completion Apr 25, 2023
Sponsor
- Lead sponsor
- Cumberland PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 23, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this phase 2 study is to assess the safety and efficacy of oral ifetroban for the treatment of aspirin-exacerbated respiratory disease (AERD). AERD is a disease that involves asthma, recurring nasal polyps, and respiratory reactions to aspirin and other nonsteroidal anti-inflammatory drugs.
Conditions
- Asthma, Aspirin-Induced
Interventions
Ifetroban Oral CapsuleDrug
Subjects will be treated with oral ifetroban daily for 8 weeks
Placebo Oral CapsuleDrug
Subjects will be treated with oral placebo daily for 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Sinonasal Outcome Test-22 ScoreTime frame: Baseline and 8 weeks
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Banner University of Arizona Medical Center, Asthma & Airway Disease Research Center
Tucson, Arizona
Antelope Valley Clinical Trials
Lancaster, California
Scripps Clinic - Carmel Valley
San Diego, California
Stanford University Medical Center
Stanford, California
The Research Center
Hialeah, Florida
Emory University School of Medicine, Sinus, Nasal, and Allergy Center
Atlanta, Georgia
Deaconess Clinic
Evansville, Indiana
Kansas City Allergy and Asthma Associates, PA
Overland Park, Kansas
Advanced ENT & Allergy
Louisville, Kentucky
Rochester Regional Health
Rochester, New York
Montefiore Medical Center
The Bronx, New York
Wake Forest Baptist Health
Winston-Salem, North Carolina
University of Pennsylvania
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
UT Southwestern Medical Center
Dallas, Texas
University of Virginia Medical Center
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.